Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy

Br J Obstet Gynaecol. 1994 Feb;101(2):158-61. doi: 10.1111/j.1471-0528.1994.tb13085.x.
No abstract available

MeSH terms

  • Adenocarcinoma / chemically induced*
  • Adenocarcinoma / pathology
  • Aged
  • Endometrial Hyperplasia / chemically induced*
  • Endometrial Hyperplasia / pathology
  • Endometrial Neoplasms / chemically induced*
  • Endometrial Neoplasms / pathology
  • Female
  • Humans
  • Menopause
  • Middle Aged
  • Norpregnenes / adverse effects*

Substances

  • Norpregnenes
  • tibolone